224 related articles for article (PubMed ID: 16382041)
21. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis.
Shen MM; Abate-Shen C
Dev Dyn; 2003 Dec; 228(4):767-78. PubMed ID: 14648854
[TBL] [Abstract][Full Text] [Related]
22. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
Ju JH; Maeng JS; Zemedkun M; Ahronovitz N; Mack JW; Ferretti JA; Gelmann EP; Gruschus JM
J Mol Biol; 2006 Jul; 360(5):989-99. PubMed ID: 16814806
[TBL] [Abstract][Full Text] [Related]
23. Expression of NKX3.1 in normal and malignant tissues.
Gelmann EP; Bowen C; Bubendorf L
Prostate; 2003 May; 55(2):111-7. PubMed ID: 12661036
[TBL] [Abstract][Full Text] [Related]
24. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
[TBL] [Abstract][Full Text] [Related]
25. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer].
Yang GS; Wang YM; Chen ZD
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):137-40, 144. PubMed ID: 16519150
[TBL] [Abstract][Full Text] [Related]
26. Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis.
Korkmaz CG; Korkmaz KS; Manola J; Xi Z; Risberg B; Danielsen H; Kung J; Sellers WR; Loda M; Saatcioglu F
J Urol; 2004 Sep; 172(3):1134-9. PubMed ID: 15311057
[TBL] [Abstract][Full Text] [Related]
27. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.
Banach-Petrosky W; Jessen WJ; Ouyang X; Gao H; Rao J; Quinn J; Aronow BJ; Abate-Shen C
Cancer Res; 2007 Oct; 67(19):9089-96. PubMed ID: 17909013
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of NKX3.1 in benign prostatic hyperplasia.
Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.
Gelmann EP; Steadman DJ; Ma J; Ahronovitz N; Voeller HJ; Swope S; Abbaszadegan M; Brown KM; Strand K; Hayes RB; Stampfer MJ
Cancer Res; 2002 May; 62(9):2654-9. PubMed ID: 11980664
[TBL] [Abstract][Full Text] [Related]
30. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
31. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
32. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers.
Voeller HJ; Augustus M; Madike V; Bova GS; Carter KC; Gelmann EP
Cancer Res; 1997 Oct; 57(20):4455-9. PubMed ID: 9377551
[TBL] [Abstract][Full Text] [Related]
33. Expression of an Nkx3.1-CRE gene using ROSA26 reporter mice.
Stanfel MN; Moses KA; Carson JA; Zimmer DB; DeMayo F; Schwartz RJ; Zimmer WE
Genesis; 2006 Nov; 44(11):550-5. PubMed ID: 17078065
[TBL] [Abstract][Full Text] [Related]
34. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.
Abdulkadir SA; Magee JA; Peters TJ; Kaleem Z; Naughton CK; Humphrey PA; Milbrandt J
Mol Cell Biol; 2002 Mar; 22(5):1495-503. PubMed ID: 11839815
[TBL] [Abstract][Full Text] [Related]
35. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
36. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
[TBL] [Abstract][Full Text] [Related]
37. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
[TBL] [Abstract][Full Text] [Related]
38. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.
Fang L; Min L; Lin Y; Ping G; Rui W; Ying Z; Xi W; Ting H; Li L; Ke D; Jihong R; Huizhong Z
Cell Signal; 2010 Jan; 22(1):166-73. PubMed ID: 19786090
[TBL] [Abstract][Full Text] [Related]
40. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
Kasper S
J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
